Search research articles
Contact Us
Filters
Showing results (441-450 of 721) with videos related to
Page
of 73
Sort By:
Journal of Clinical Medicine
|
October 2, 2020
<sup>18</sup>F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
Yan Li, Laura Isabel Mueller, Jan Peter Neuhaus, et al.
Radiology
|
July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
Andrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
Life (Basel, Switzerland)
|
April 30, 2021
Theranostics in Boron Neutron Capture Therapy
Wolfgang A G Sauerwein, Lucie Sancey, Evamarie Hey-Hawkins, et al.
EJNMMI Research
|
May 16, 2015
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Constantin Lapa, Rudolf A Werner, Christina Bluemel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 1, 2010
First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT
Thomas Wendler, Ken Herrmann, Andreas Schnelzer, et al.
Theranostics
|
April 1, 2015
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging
Hans Jürgen Wester, Ulrich Keller, Margret Schottelius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Renal and Multiorgan Safety of <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
Ken Herrmann, Kambiz Rahbar, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 23, 2016
Synthesis and preclinical evaluation of an Al<sup>18</sup>F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand
Stefano Boschi, Jason T Lee, Seval Beykan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 27, 2017
Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
Wolfgang P Fendler, Andreea D Stuparu, Susan Evans-Axelsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 5, 2022
EANM practice guideline for quantitative SPECT-CT
John C Dickson, Ian S Armstrong, Pablo Minguez Gabiña, et al.
Page
of 73
Search research articles
Search
Showing results (441-450 of 721) with videos related to
Sort By:
Page
of 73
Journal of Clinical Medicine
|
October 2, 2020
<sup>18</sup>F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer: What Is the Benefit of PET?
Yan Li, Laura Isabel Mueller, Jan Peter Neuhaus, et al.
Radiology
|
July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
Andrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
Life (Basel, Switzerland)
|
April 30, 2021
Theranostics in Boron Neutron Capture Therapy
Wolfgang A G Sauerwein, Lucie Sancey, Evamarie Hey-Hawkins, et al.
EJNMMI Research
|
May 16, 2015
Prediction of clinically relevant hyperkalemia in patients treated with peptide receptor radionuclide therapy
Constantin Lapa, Rudolf A Werner, Christina Bluemel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 1, 2010
First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT
Thomas Wendler, Ken Herrmann, Andreas Schnelzer, et al.
Theranostics
|
April 1, 2015
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging
Hans Jürgen Wester, Ulrich Keller, Margret Schottelius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2023
Renal and Multiorgan Safety of <sup>177</sup>Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
Ken Herrmann, Kambiz Rahbar, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 23, 2016
Synthesis and preclinical evaluation of an Al<sup>18</sup>F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand
Stefano Boschi, Jason T Lee, Seval Beykan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 27, 2017
Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
Wolfgang P Fendler, Andreea D Stuparu, Susan Evans-Axelsson, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 5, 2022
EANM practice guideline for quantitative SPECT-CT
John C Dickson, Ian S Armstrong, Pablo Minguez Gabiña, et al.
Page
of 73